Noticias de UTHR_US

Mercado

Noticias del mercado

Últimas noticias sobre UTHR_US — 297 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: UTHR_US ✕ 297 resultados
06/08/2026 UTHR_US — Investing.com
BofA cuts United Therapeutics stock price target on Tyvaso sales By Investing.com
05/08/2026 UTHR_US — Investing.com ES ← EN
BofA recorta el precio objetivo de las acciones de United Therapeutics por las ventas de Tyvaso Por Investing.com

BofA cuts United Therapeutics stock price target on Tyvaso sales By Investing.com

05/08/2026 UTHR_US — GuruFocus ES ← EN
United Therapeutics Corp (UTHR) (segundo trimestre de 2026) Llamada destacada sobre resultados

United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highligh

05/08/2026 UTHR_US — Investing.com
BofA cuts United Therapeutics stock price target on Tyvaso sales By Investing.com
05/08/2026 UTHR_US — Investing.com
BofA cuts United Therapeutics stock price target on Tyvaso sales By Investing.com
05/08/2026 UTHR_US — Minichart
United Therapeutics Q2 2026 Earnings Report: Strong Revenue, Rising Net Income, and Financial Highlights
05/08/2026 UTHR_US — GuruFocus
Is United Therapeutics Corp (UTHR) Overvalued After Q2 Earnings
05/08/2026 UTHR_US — ChartMill ES ← EN
United Therapeutics (NASDAQ:UTHR) cae mientras los ingresos del segundo trimestre no alcanzan a pesar del aumento de las EPS

United Therapeutics (NASDAQ:UTHR) Tumbles as Q2 Revenue Misses Despite EPS Beat

05/08/2026 UTHR_US — TradingKey
United Therapeutics Q2 2026 earnings: Lower taxes lift EPS as revenue slips
05/08/2026 UTHR_US — Yahoo Finance
United Therapeutics: Q2 Earnings Snapshot

En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.

05/08/2026 UTHR_US — Barchart.com
United Therapeutics: Q2 Earnings Snapshot
05/08/2026 UTHR_US — Stock Titan
Net income $607.9M and $1.5B buyback at United Therapeutics (NASDAQ: UTHR)
05/08/2026 UTHR_US — Stock Titan ES ← EN
United Therapeutics espera la aprobación de dos posibles medicamentos el próximo año

United Therapeutics Expects Two Potential Drug Approvals Next Year

05/08/2026 UTHR_US — Yahoo Finance
United Therapeutics Corporation Q2 2026 Earnings Call Summary
05/08/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 plan
05/08/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) lifts Q2 EPS, details $2.0B share buyback plan
05/08/2026 UTHR_US — Yahoo Finance
United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress ...

La empresa avanza en presentaciones regulatorias clave para Tyvaso y ralinepag mientras navega por las presiones competitivas en el mercado de prostaciclina inhalada.

05/08/2026 UTHR_US — GuruFocus
United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highligh
05/08/2026 UTHR_US — Investing.com
BofA cuts United Therapeutics stock price target on Tyvaso sales
05/08/2026 UTHR_US — Yahoo Finance
United Therapeutics Q2 Earnings Call Highlights

Página 13 de 15